CN106937746A - 硒加钙软胶囊及制备方法 - Google Patents
硒加钙软胶囊及制备方法 Download PDFInfo
- Publication number
- CN106937746A CN106937746A CN201710166454.XA CN201710166454A CN106937746A CN 106937746 A CN106937746 A CN 106937746A CN 201710166454 A CN201710166454 A CN 201710166454A CN 106937746 A CN106937746 A CN 106937746A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- calcium
- selenium
- glue
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011575 calcium Substances 0.000 title claims abstract description 61
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 60
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 60
- 239000011669 selenium Substances 0.000 title claims abstract description 59
- 239000007901 soft capsule Substances 0.000 title claims abstract description 51
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 40
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims abstract description 14
- 108010010803 Gelatin Proteins 0.000 claims abstract description 13
- 235000013871 bee wax Nutrition 0.000 claims abstract description 13
- 239000012166 beeswax Substances 0.000 claims abstract description 13
- 239000008273 gelatin Substances 0.000 claims abstract description 13
- 229920000159 gelatin Polymers 0.000 claims abstract description 13
- 235000019322 gelatine Nutrition 0.000 claims abstract description 13
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 235000011187 glycerol Nutrition 0.000 claims abstract description 7
- 239000008213 purified water Substances 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000003292 glue Substances 0.000 claims description 19
- 239000002994 raw material Substances 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 238000005453 pelletization Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000004513 sizing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000001993 wax Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 241000282414 Homo sapiens Species 0.000 abstract description 22
- 210000000988 bone and bone Anatomy 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 230000029142 excretion Effects 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 230000033001 locomotion Effects 0.000 abstract description 3
- 229940091258 selenium supplement Drugs 0.000 description 34
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 9
- 206010039921 Selenium deficiency Diseases 0.000 description 8
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 229960004488 linolenic acid Drugs 0.000 description 8
- 230000037396 body weight Effects 0.000 description 7
- 235000004347 Perilla Nutrition 0.000 description 6
- 241000229722 Perilla <angiosperm> Species 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 210000001550 testis Anatomy 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 3
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229960001471 sodium selenite Drugs 0.000 description 3
- 239000011781 sodium selenite Substances 0.000 description 3
- 235000015921 sodium selenite Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000021323 fish oil Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 201000011461 pre-eclampsia Diseases 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001694 thigh bone Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- ARSRBNBHOADGJU-UHFFFAOYSA-N 7,12-dimethyltetraphene Chemical compound C1=CC2=CC=CC=C2C2=C1C(C)=C(C=CC=C1)C1=C2C ARSRBNBHOADGJU-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- VFZRZRDOXPRTSC-UHFFFAOYSA-N DMBA Natural products COC1=CC(OC)=CC(C=O)=C1 VFZRZRDOXPRTSC-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 208000031320 Teratogenesis Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000001479 atomic absorption spectroscopy Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000003927 comet assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000014105 formulated food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 231100000437 hepatocellular injury Toxicity 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 238000001277 hydride generation atomic absorption spectroscopy Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000014511 neuron projection development Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000000209 wet digestion Methods 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组别 | 剂量(mg/kg•bw) | 始长/cm | 第4周身长/cm | 始重/g | 第13周重/g |
低钙对照组 | 0 | 14.88±0.18 | 20.31±0.67** | 80.33±5.50 | 323.55±38.50** |
碳酸钙对照组 | 160 | 14.86±0.38 | 21.50±0.71 | 80.48±7.68 | 375.55±36.50 |
低剂量组 | 25 | 14.80±0.26 | 21.09±0.58 | 80.75±5.54 | 343.97±34.53** |
中剂量组 | 50 | 14.90±0.12 | 21.95±0.93 | 80.82±5.25 | 454.85±48.24** |
高剂量组 | 150 | 14.70±0.35 | 22.67±0.76** | 80.88±6.76 | 506.48±54.25** |
组别 | 剂量(mg/kg•bw) | 摄入钙/mg•d-1 | 粪便钙含量/mg•g-1 | 粪钙/mg•d-1 | 钙的表观吸收率/ % |
低钙对照组 | 0 | 48.2±2.9 | 0.57±0.15** | 0.77±0.25 | 98.34±0.56** |
碳酸钙对照组 | 160 | 64.3±1.9 | 0.58±0.52 | 2.47±0.72 | 95.98±1.26 |
低剂量组 | 25 | 57.6±4.9 | 0.64±0.12** | 0.95±0.35 | 98.19±0.66** |
中剂量组 | 50 | 52.6±4.8 | 0.71±0.18** | 1.27±0.33 | 97.74±0.56** |
高剂量组 | 150 | 62.3±3.9 | 0.79±0.15** | 1.41±0.55 | 97.74±0.76* |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710166454.XA CN106937746A (zh) | 2017-03-20 | 2017-03-20 | 硒加钙软胶囊及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710166454.XA CN106937746A (zh) | 2017-03-20 | 2017-03-20 | 硒加钙软胶囊及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106937746A true CN106937746A (zh) | 2017-07-11 |
Family
ID=59464384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710166454.XA Pending CN106937746A (zh) | 2017-03-20 | 2017-03-20 | 硒加钙软胶囊及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106937746A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108295116A (zh) * | 2018-02-09 | 2018-07-20 | 南京邦康生物技术有限公司 | 一种富硒保健组合物、胶囊及其制备方法 |
CN111643608A (zh) * | 2020-07-02 | 2020-09-11 | 石药集团远大(大连)制药有限公司 | 一种治疗胃病的药物组合物及其用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
CN103190615A (zh) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | 一种液体钙软胶囊及其制备方法 |
CN105077268A (zh) * | 2015-07-10 | 2015-11-25 | 江苏艾兰得营养品有限公司 | 一种含有多种维生素和植物提取物以及微量元素的软胶囊制剂及其制备方法 |
-
2017
- 2017-03-20 CN CN201710166454.XA patent/CN106937746A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101810336A (zh) * | 2010-04-30 | 2010-08-25 | 广东仙乐制药有限公司 | 一种咀嚼性软胶囊及其制备方法 |
CN103190615A (zh) * | 2013-04-03 | 2013-07-10 | 上海春芝堂生物制品有限公司 | 一种液体钙软胶囊及其制备方法 |
CN105077268A (zh) * | 2015-07-10 | 2015-11-25 | 江苏艾兰得营养品有限公司 | 一种含有多种维生素和植物提取物以及微量元素的软胶囊制剂及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108295116A (zh) * | 2018-02-09 | 2018-07-20 | 南京邦康生物技术有限公司 | 一种富硒保健组合物、胶囊及其制备方法 |
CN111643608A (zh) * | 2020-07-02 | 2020-09-11 | 石药集团远大(大连)制药有限公司 | 一种治疗胃病的药物组合物及其用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101156679B (zh) | 米糠营养原液及其制作方法 | |
CN103800435B (zh) | 一种海狗油软胶囊 | |
CN105613789A (zh) | 一种高脂高膳食纤维复合动植物粉末油脂、其制备方法及应用 | |
CN101473953A (zh) | 净血排毒组合食品及其加工方法和应用 | |
CN107136511A (zh) | 一种促进脑神经发育的牡丹籽油组合物、牡丹籽油软胶囊及其制备方法 | |
CN101720939A (zh) | 一种大鲵肉骨粉胶囊、制备方法及其用途 | |
CN102586066B (zh) | 一种保健酒及其制备方法 | |
CN101152281A (zh) | 一种复方玫瑰精油软胶囊及其制备方法 | |
CN106937746A (zh) | 硒加钙软胶囊及制备方法 | |
CN109965271A (zh) | 一种小儿脑发育专用型临床营养配方及其制备方法 | |
CN109170916A (zh) | 一种强身健体食品组合物及其制备方法 | |
CN109156530A (zh) | 一种辅食营养包及其生产工艺 | |
CN108902719A (zh) | 一种保健面条及其制备方法 | |
CN100542414C (zh) | 一种功能型口香糖及其制备方法 | |
CN111771970A (zh) | 有助于养胃、护胃的组合物及其制备方法 | |
CN1270624C (zh) | 一种花粉、蜂王浆食品及其制备方法 | |
KR101512230B1 (ko) | 면역력 및 혈액순환 개선 기능을 갖는 관절염 치료 조성물과 그 제조방법 | |
CN101715984A (zh) | 一种螺旋藻胶囊及其生产制作工艺 | |
CN108902965A (zh) | 一种补血复方肽功能食品及其制备方法 | |
CN110623073A (zh) | 一种有利于身体长高的配方奶粉及其制备方法 | |
CN112715933A (zh) | 一种蜂王浆胶囊及其制备方法 | |
CN101167493A (zh) | 一种富含辅酶q10的乳制品及其制备方法 | |
CN101233909B (zh) | 高级豆腐及其制备工艺 | |
RU2363268C1 (ru) | Биологически активная добавка к пище | |
CN102742760A (zh) | 一种适合中老年女性食用的高蛋白营养粉 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181221 Address after: 150 000 Unit 302, 299 Dongda Zhijie, Nangang District, Harbin City, Heilongjiang Province Applicant after: Harbin Dong Zhuan Science and Technology Ltd. Address before: 150076 Huanan County Economic Development Zone, Jiamusi City, Heilongjiang Province Applicant before: Huanan Xian purple food science and Technology Co Ltd |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190325 Address after: 150 000 Huanan Economic Development Zone, Huanan County, Jiamusi City, Heilongjiang Province Applicant after: Huanan Xian purple food science and Technology Co Ltd Address before: 150 000 Unit 302, 299 Dongda Zhijie, Nangang District, Harbin City, Heilongjiang Province Applicant before: Harbin Dong Zhuan Science and Technology Ltd. |
|
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170711 |